...
首页> 外文期刊>Emerging Infectious Diseases >Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms
【24h】

Ethics of Infection Control Measures for Carriers of Antimicrobial Drug–Resistant Organisms

机译:抗菌药物耐药菌携带者感染控制措施的伦理

获取原文

摘要

Many countries have implemented infection control measures directed at carriers of multidrug-resistant organisms. To explore the ethical implications of these measures, we analyzed 227 consultations about multidrug resistance and compared them with the literature on communicable disease in general. We found that control measures aimed at carriers have a range of negative implications. Although moral dilemmas seem similar to those encountered while implementing control measures for other infectious diseases, 4 distinct features stand out for carriage of multidrug-resistant organisms: carriage presents itself as a state of being; carriage has limited relevance for the health of the carrier; carriage has little relevance outside healthcare settings; and antimicrobial resistance is a slowly evolving threat on which individual carriers have limited effect. These features are of ethical relevance because they influence the way we traditionally think about infectious disease control and urge us to pay more attention to the personal experience of the individual carrier.
机译:许多国家已经针对多药耐药生物的携带者实施了感染控制措施。为了探讨这些措施的伦理意义,我们分析了227项关于多药耐药性的咨询,并将其与一般传染病文献进行了比较。我们发现针对航母的控制措施具有一系列负面影响。尽管在道德困境上似乎与实施其他传染病控制措施时所遇到的困境相似,但在携带多药耐药生物的过程中,有四个鲜明的特点:运输表现为一种存在状态;运输对承运人的健康影响有限;在医疗机构以外,运输没有什么意义;抗菌素耐药性是一个缓慢发展的威胁,单个载体对其的作用有限。这些特征具有伦理意义,因为它们会影响我们传统上对传染病控制的思考方式,并敦促我们更加关注各个携带者的个人经历。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号